Monoclonal Antibody Therapy in Rheumatoid Arthritis: A Paradigm Shift Toward Precision Immunotherapy
Journal of Young Pharmacists · 26.06.2026 · 18 (2) · 260-266
DOI: 10.5530/jyp.20260217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Young Pharmacists, online erschienen am 26.06.2026. Verfasst von Kannaiyan Suria Prabha und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Prabha, K. S., Albert, J., Grace, D. C., Gokul, S. K., Kumar, S. K., Sundar, G. S., & Kumar, R. U. (2026). Monoclonal Antibody Therapy in Rheumatoid Arthritis: A Paradigm Shift Toward Precision Immunotherapy. Journal of Young Pharmacists, 18(2), 260-266. https://doi.org/10.5530/jyp.20260217
Vancouver
Prabha KS, Albert J, Grace DC, Gokul SK, Kumar SK, Sundar GS, et al. Monoclonal Antibody Therapy in Rheumatoid Arthritis: A Paradigm Shift Toward Precision Immunotherapy. Journal of Young Pharmacists. 2026;18(2):260-266. doi:10.5530/jyp.20260217
BibTeX
@article{Prabha2026,
author = {Prabha, Kannaiyan Suria and Albert, Joshua and Grace, Daniel Catherine and Gokul, Selva Kumar and Kumar, Sankar Kalai and Sundar, Ganesan Shyam and Kumar, Ravichandran Udaya},
title = {Monoclonal Antibody Therapy in Rheumatoid Arthritis: A Paradigm Shift Toward Precision Immunotherapy},
journal = {Journal of Young Pharmacists},
year = {2026},
volume = {18},
number = {2},
pages = {260--266},
doi = {10.5530/jyp.20260217}
}
EUVIMED